성장을 멈추지 마세요

체험은 만족하셨나요?

현재 45,782명이 마이메르시로 공부 중이에요

지식 자료를 소장하고 멋진 의료인으로 성장하세요

학습 자료 둘러보기 →
COVID-19 (Coronavirus) | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

0 / 2000
컨텐츠 수정하기

컨텐츠 내용을 수정할 수 있습니다

수정하기
닫기

COVID-19 (Coronavirus)

NCLEX Review Guide: COVID-19 Pharmacology & Respiratory Management

COVID-19 Pathophysiology & Respiratory Impact

SARS-CoV-2 Mechanism

  • SARS-CoV-2 binds to ACE2 receptors primarily in lung tissue, causing inflammatory cascade and potential ARDS development.
  • Virus replication leads to cytokine storm, resulting in severe systemic inflammation and multi-organ dysfunction.

Key Points

  • ACE2 receptors are abundant in lungs, heart, kidneys, and GI tract
  • Inflammatory response can progress to ARDS within 7-14 days

Pharmacological Management

Antiviral Medications

  • Remdesivir is FDA-approved antiviral that inhibits viral RNA polymerase, reducing hospitalization duration by 1-4 days.
  • Paxlovid (nirmatrelvir-ritonavir) is oral antiviral for high-risk patients within 5 days of symptom onset.
Important Alert: Remdesivir requires daily kidney function monitoring due to potential nephrotoxicity

Anti-inflammatory Therapy

  • Dexamethasone 6mg daily for 10 days reduces mortality in patients requiring oxygen support or mechanical ventilation.
  • Tocilizumab (IL-6 receptor antagonist) used for severe COVID-19 with hyperinflammatory response.

Memory Aid: COVID Steroid Rule

"Six for Sick" - Dexamethasone 6mg for patients sick enough to need oxygen

Respiratory Support & Monitoring

Oxygen Therapy Progression

  1. Nasal cannula (1-6 L/min) for mild hypoxemia (SpO2 88-92%)
  2. High-flow nasal cannula (HFNC) for moderate hypoxemia with increased work of breathing
  3. Non-invasive ventilation (BiPAP/CPAP) for severe hypoxemia without improvement
  4. Mechanical ventilation for respiratory failure or ARDS

Clinical Scenario

Patient with COVID-19 pneumonia has SpO2 89% on room air, RR 28, using accessory muscles. Priority intervention: Apply oxygen via nasal cannula and assess for improvement before escalating support.

Commonly Confused Concepts

Medication Indication Key Monitoring Contraindications
Remdesivir Hospitalized patients Creatinine, LFTs eGFR <30, ALT >10x ULN
Paxlovid Outpatient high-risk Drug interactions Severe renal/hepatic impairment
Dexamethasone Oxygen-requiring patients Blood glucose, infection Systemic fungal infections

Study Tips & Memory Aids

Steroid Timing Mnemonic

"DEXA-TEN" - DEXAmethasone for TEN days, but only for oxygen-dependent patients

Remdesivir Monitoring

"REM-Kid-Liver" - REMdesivir requires KIDney and LIVER function monitoring

Common Pitfall: Do NOT give dexamethasone to COVID patients who don't require oxygen - it may worsen outcomes in mild cases

Quick Check Questions

  • ☐ Can you identify when to start dexamethasone in COVID patients?
  • ☐ Do you know the difference between Remdesivir and Paxlovid indications?
  • ☐ Can you describe the oxygen therapy escalation sequence?
  • ☐ Do you understand why steroids aren't given to all COVID patients?

Remember: You're preparing to save lives! Master these COVID-19 concepts to provide excellent patient care during respiratory emergencies. Every medication and intervention you learn brings you closer to becoming the nurse your patients need. Keep studying - you've got this! 🏥💪

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.